Clene Awaits US Patent Covering Gold Nanocrystals’ Use in Treating MS

Clene Awaits US Patent Covering Gold Nanocrystals’ Use in Treating MS

283590

Clene Awaits US Patent Covering Gold Nanocrystals’ Use in Treating MS

Clene Nanomedicine has been notified it will be given a U.S. patent, as requested, covering an invention using the company’s already patented gold nanocrystals for the treatment of multiple sclerosis (MS). A Notice of Allowance was received by the company. These notices are issued by the U.S. Patent and Trademark Office (USPTO) to indicate an examiner has determined an application merits the requested patent being issued. According to Clene, its gold nanocrystals are free from…

You must be logged in to read/download the full post.